Dr. Neil Wang

Dr. Neil Wang is the founder of Frost & Sullivan’s business in China, and now he is the Global Senior VP, Co-Chairman of Asia Pacific, and Chairman of China. He also holds the title of Industry Practice Professor for Industry-Education Integration at the SME Development Promotion Center of the Ministry of Industry and Information Technology. Additionally, he is a Shanghai Business Environment Experience Officer and a council member of both the China Advertising Association and the China Market Information Research Association.

Dr Neil Wang, as one of the leading figures of investment strategy consulting service in China, has over 20 years of outstanding experience in consulting services for multinational companies and leading businesses in Asia Pacific region, especially in Greater China.

For 28 years, led by Dr. Neil Wang, Frost & Sullivan’s team has combined 65 years of consulting experience with a global perspective to help clients accelerate their growth and achieve advanced positions in growth, science and innovation, and leadership in their industries. Frost & Sullivan provides service to 10,000+ clients worldwide, including emerging companies, SME, the Global 1,000 and the investment community, to achieve financial leverage goals such as financing and listing.

Dr. Neil Wang has led Frost & Sullivan’s team since 2003. Dr. Wang is credited with pioneering professional industry consulting service offerings for listings on the stock Exchange of Hong Kong and other stock exchanges globally. Dr. Neil Wang was at the helm of firstly establishing and standardizing business processes and service level standards of industry consultants for investment and financing, making great achievements and contributions in setting up industry standards. Dr. Neil Wang also took part in the solicitation of revision opinions of biotech company listing on the Main Board under Chapter 18A of the Listing Rules published by the Hong Kong Stock Exchange.

Frost & Sullivan 's team has been providing investment and financing consulting services for corporate leaders and their management teams, and has helped nearly 3,000 companies successfully list in Hong Kong and overseas. From 2015 to 2025, Frost & Sullivan was recognized as the leading champion in the market of IPO as independent industry consultant by market share. The Frost & Sullivan report has also been widely cited in the listing documents of leading A-share listed companies and listed companies on the STAR Market, etc. in the industry, as well as primary and secondary market research reports and other capital market documents. In addition, Frost & Sullivan has developed a comprehensive suite of market-positioning research tools and methodologies, and has established an innovative “Frost & Sullivan Brand Value (FSBV)” Model, and has provided market positioning research and brand valuation services to over 1,000 enterprises, consistently supporting numerous Chinese brands in their journey，both domestic and abroad，towards future growth.

In addition to leading Frost & Sullivan to achieve many successes in the Asia Pacific region, Dr. Neil Wang also founded "LeadLeo", a leading digital research and value-growth empowerment platform in China, which is widely recognized by the government, financial institutions, investors, enterprises, academic, professional service providers, R&D institutions and media by serving technical innovative and Digital China Planning, carbon neutralization and other major initiatives. In 2022, the selected publications of LeadLeo were included and uploaded to the database of Refinitiv, one of the global leading financial information platforms, which greatly helps Chinese enterprises attract investments from both home and abroad.